造影剤市場は、5,599.6 米ドルから 2028 年までに 83 億 9,110 万米ドルに達すると予測されています2022年には100万人。 2022 年から 2028 年にかけて 7.0% の CAGR で成長すると予想されています。
造影剤は、身体を通る超音波または電磁放射線の通過方法を変更することにより、標的組織の放射線密度を高めるために使用される物質です。これらの物質は、直腸、経口、または静脈内に投与できます。造影剤の種類の選択は、イメージングのモダリティと目的によって異なります。慢性疾患の有病率の増加、造影剤の承認数の増加、および画像診断モダリティの発展は、市場の成長に貢献する重要な要因の1つです。ただし、造影剤の副作用により、造影剤の使用が妨げられます。
造影剤市場は次のように分類されます。種類、画像の可動性、適応症、投与経路、および地理の基礎。このレポートは、市場の傾向、技術の進歩、市場のダイナミクス、(主要な市場プレーヤーの)競争状況の分析などのパラメーターを強調して、市場の洞察と詳細な分析を提供します。
>戦略的洞察
造影剤市場の有利な地域
マーケット インサイト
< h3>慢性疾患の発生率と有病率の増加が市場の成長を促進
慢性心血管疾患、呼吸器疾患、整形外科疾患、およびさまざまな種類のがんが障害や死亡につながっています。世界的に。これらの臨床状態は、全体的な生活の質に影響を与えます。世界保健機関 (WHO) によると、世界人口の約 50% が少なくとも 1 つの慢性疾患に苦しんでいると推定されています。米国疾病管理予防センター (CDC) は、2019 年に米国の 10 人中 6 人が少なくとも 1 つの慢性疾患を患っていたと発表しました。心血管疾患 (CVD) は世界的に重大な死亡原因となっています。米国心臓協会によると、米国では心不全の発生率が増加しています。 2019 年、米国では 874,613 人が CVD により死亡しました。 Single Care が発表した記事によると、2021 年には世界で 3 億 5,000 万人を超える人が関節炎を抱えて暮らしています。米国、日本、韓国、カナダ、英国、スペイン、フランス (および中国、インド、サウジアラビア、アラブ首長国連邦、ブラジルなど)では、高齢者人口が大幅に増加しており、関節炎のリスクが高まっています。したがって、慢性疾患の有病率の増加により、X 線/CT、磁気共鳴画像法と超音波が、世界の造影剤市場の成長を牽引しています。
< h3>管理ベースの洞察のルート
造影剤市場は、投与経路に基づいて、血管内、経口、直腸に分類されます。血管内セグメントは 2022 年に最大の市場シェアを保持し、予測期間中に最高の CAGR を記録すると予想されます。このセグメントの市場成長は、体のあらゆる部分に物質を送達できる造影剤注射の広く使用によるものです。
画像モダリティベースの洞察
造影剤市場は、イメージングモダリティに基づいて、X 線/CT、磁気共鳴画像法、および超音波に分類されます。 2022 年には X 線/CT セグメントが最大の市場シェアを占めました。ただし、超音波セグメントは 2022 年から 2028 年にかけて最も高い CAGR を記録すると予測されています。
北米は造影剤市場で大きなシェアを占めており、予測期間中に同様の傾向を示すと予想されます。米国はこの地域における造影剤の最大の消費国である。最初のガドリニウムベースの造影剤が米国で承認されました。さらに、過去 10 年間にさらに 4 つの薬剤が米国で FDA の承認を受けており、この国ではより効率的で安全かつ正確な薬剤の導入に向けた強い傾向が示されています。さらに、神経疾患や心血管疾患などの慢性疾患の発生率の急増が、米国の造影剤市場の成長を促進する主な要因となっています。造影剤の需要は、すべての画像診断法の中でも超音波技術においてかなり高くなります。
造影剤市場はタイプに基づいて分類されますタイプに基づいて、市場はヨード造影剤、ガドリニウムベースの造影剤、バリウムベースの造影剤、およびマイクロバブル造影剤に分類されます。画像診断モダリティの観点から、市場は X 線/CT、磁気共鳴画像法、および超音波に分割されます。適応症に基づいて、市場は心血管障害、がん、胃腸障害、筋骨格系障害、神経障害および腎臓障害。造影剤市場は、投与経路によって血管内、経口、直腸に分類されます。地理に基づいて、市場は北米(米国、カナダ、メキシコ)、ヨーロッパ(英国、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ)、アジア太平洋(中国、日本、インド、韓国)に分割されています。 、オーストラリア、その他のアジア太平洋地域)、中東およびその他の地域アフリカ (UAE、サウジアラビア、南アフリカ、その他の中東およびアフリカ)、および南およびアフリカ。中央アメリカ (ブラジル、アルゼンチン、およびその他の南米および中米)。
会社概要
- ゼネラル エレクトリック
- バイエル AG
- ブラッコ
- ゲルベ
- Lantheus Medical Imaging Inc< /span>
- nanoPET Pharma GmbH
- Unijules Life Science Ltd
- Magnus Health Management Pvt Ltd
- JB Chemical and Pharmaceuticals Ltd
- ジョーダンエクスポイム
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. General Electric
2. Bayer AG
3. Bracco
4. GUERBET
5. Lantheus Medical Imaging, Inc.
6. nanoPET Pharma GmbH
7. Unijules Life Sciences Ltd.
8. Magnus Health Management Pvt Ltd.
9. J.B.Chemicals and Pharmaceuticals Ltd.
10. Jodas Expoim
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)